Quantcast

L'Oreal USA


Recent News About L'Oreal USA View More

L'Oreál accused of marketing cosmetic line as 'skin-altering drugs' without FDA approval

By Marian Johns | Mar 13, 2019

LOS ANGELES (Legal Newsline)— A California woman has filed a class action lawsuit against L'Oreál USA, Inc., alleging its skin care cosmetic products are being marketed as "skin-altering drugs" without Food and Drug Administration approval.

The Record Network